CAPÍTULO 3: Manifestaciones clínicas axiales y periféricas de las espondiloartritis axiales

Romina Nieto; Hernán Maldonado-Ficco; Pamela Giorgis

Romina Nieto Grupo Oroño, Rosario, Santa Fe, Argentina
Hernán Maldonado-Ficco Hospital San Antonio de Padua, Río Cuarto, Córdoba, Argentina
Pamela Giorgis Centro de Investigaciones Médicas Tucumán, Tucumán, Argentina

Palabras clave: espondiloartritis axial, manifestaciones, artritis perifética, entesitis

Resumen

La espodiloartritis (EspA) puede presentarse con afectación predominantemente axial o periférica denominándose EspA axial (EspAax) o EspA periférica (EspAp), respectivamente. La EspAax afecta principalmente a las articulaciones sacroilíacas y la columna vertebral, siendo la espondilitis anquilosante (EA) o EspAax radiográfica (EspAax-r) el prototipo de estas enfermedades. Resulta dificultoso establecer la prevalencia debido a la heterogeneidad étnica de la población, la falta de viabilidad de aplicar los criterios actuales (pruebas de HLA-B27 y los estudios de imágenes, como la radiografía pélvica y la resonancia magnética) y la naturaleza transitoria de algunos síntomas de EspA (artritis periférica y entesitis). Según la Encuesta Nacional de Examen de Salud y Nutrición (2009-2010) se estimó que la prevalencia de EspAax varía del 0,9% al 1,4% en la población adulta en los Estados Unidos. En América Latina, a través de una revisión de la literatura, se determinó la prevalencia de EspA y sus subtipos, la cual que varió de 0,28 a 0,9% (EspA), 0,02 a 0,8% (EA), 0,2 a 0,9% (EspAax) y 0,004 a 0,08% (artritis psoriásica- APs).

Biografía del autor/a

Romina Nieto, Grupo Oroño, Rosario, Santa Fe, Argentina

Hospital Escuela Eva Perón, Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR)

Hernán Maldonado-Ficco, Hospital San Antonio de Padua, Río Cuarto, Córdoba, Argentina

Hospital San Antonio de Padua

Pamela Giorgis, Centro de Investigaciones Médicas Tucumán, Tucumán, Argentina

Centro de Investigaciones Médicas Tucumán

Citas

I. Ceribelli A, Motta F, Vecellio M, Isailovic N, Ciccia F, Selmi C. Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis. Front Immunol. 2021;12:622770.

II. Danve A, Deodhar A. Axial spondyloarthritis in the USA: diagnostic challenges and missed opportunities. Clin Rheumatol. 2019;38(3):625-634

III. Reveille JD. Epidemiology of spondyloarthritis in North America. Am J Med Sci. 2011;341(4):284-6.

IV. Walsh JA, Magrey M. Clinical manifestations and diagnosis of axial spondyloarthritis. J Clin Rheumatol. 2021;27(8):e547-e560.

V. Citera G, Bautista-Molano W, Peláez-Ballestas I, Azevedo VF, Perich RA, Méndez-Rodríguez JA, Cutri MS, Borlenghi CE. Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis. Adv Rheumatol. 2021;61(1):2.

VI. Schneeberger E, Citera G, Soriano E, Gentiletti J, Somma L, Carlevaris L, et al. Prevalencia de espondiloartritis axial diagnosticada en Argentina (Estudio PRESPAX). Congreso Argentino de Reumatología (2023). Posters. Rev Arg Reumatol. 2023, 34(Sup1), 22 - 90.

VII. Sieper J, van der Heijde D, Landewé R, Brandt J, Burgos-Vagas R, Collantes-Estevez E, et al. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis. 2009;68(6):784-8.

VIII. Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R, et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis. 2009 ;68 Suppl 2:ii1-44.

IX. Sieper J, Srinivasan S, Zamani O, Mielants H, Choquette D, Pavelka K, et al. Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) study. Ann Rheum Dis. 2013;72(10):1621-7.

X. Solmaz D, Akar S, Soysal O, Akkoc Y, Can G, Gerdan V, et al. Performance of different criteria sets for inflammatory back pain in patients with axial spondyloarthritis with and without radiographic sacroiliitis. Clin Rheumatol. 2014;33(10):1475-9.

XI. Poddubnyy D, Callhoff J, Spiller I, Listing J, Braun J, Sieper J, Rudwaleit M. Diagnostic accuracy of inflammatory back pain for axial spondyloarthritis in rheumatological care. RMD Open. 2018;4(2):e000825.

XII. Citera G, Maldonado Cocco J, Anaya JM. Caracterización inmunogenética de pacientes con espondilitis anquilosante en Argentina. Rev argent reumatol, 2009. 20(3):26-33.

XIII. Calin A, Porta J, Fries JF, Schurman DJ. Clinical history as a screening test for ankylosing spondylitis. JAMA. 1977;237(24):2613-4.

XIV. Rudwaleit M, Metter A, Listing J, Sieper J, Braun J. Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum. 2006;54(2):569-78.

XV. Rudwaleit M, van der Heijde D, Landewé R, Akkoc N, Brandt J, Chou CT, et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis. 2011;70(1):25-31.

XVI. de Winter JJ, van Mens LJ, van der Heijde D, Landewé R, Baeten DL. Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis. Arthritis Res Ther. 2016;18(1):196.

XVII. Mease PJ, Heijde DV, Karki C, Palmer JB, Liu M, Pandurengan R, et al. Characterization of Patients With Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis in the US-Based Corrona Registry. Arthritis Care Res (Hoboken). 2018;70(11):1661-1670.

XVIII. Benegas M, Muñoz-Gomariz E, Font P, Burgos-Vargas R, Chaves J, Palleiro D, et al. RESPONDIA group; ASPECT study group; REGISPONSER study group. Comparison of the clinical expression of patients with ankylosing spondylitis from Europe and Latin America. J Rheumatol. 2012;39(12):2315-20.

XIX. Bautista-Molano W, Landewé R, Burgos-Vargas R, Maldonado-Cocco J, Moltó A, van den Bosch F, et al. Prevalence of Comorbidities and Risk Factors for Comorbidities in Patients with Spondyloarthritis in Latin America: A Comparative Study with the General Population and Data from the ASAS-COMOSPA Study. J Rheumatol. 2018;45(2):206-212.

XX. Kishimoto M, Yoshida K, Ichikawa N, Inoue H, Kaneko Y, Kawasaki T, et al. Clinical characteristics of patients with spondyloarthritis in Japan in comparison with other regions of the world. J Rheumatol. 2019;46(8):896-903.

XXI. López-Medina C, Moltó A, Dougados M. Peripheral manifestations in spondyloarthritis and their effect. An ancillary analysis of the ASAS-COMOSPA study. J Rheumatol. 2020;47(2):211-217.

XXII. López-Medina C, Molto A, Sieper J, Duruöz T, Kiltz U, Elzorkany B, et al. Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study. RMD Open. 2021;7(1):e001450.

XXIII. Amor B, et al. Predictive factors for the longterm outcome of spondyloarthropathies. J Rheumatol, 1994. 21(10): p. 1883-7.

XXIV. Vander Cruyssen B, Vastesaeger N, Collantes-Estévez E. Hip disease in ankylosing spondylitis. Curr Opin Rheumatol. 2013;25(4):448-54.

XXV. Jung JH, Bang CH, Seok H, Choi SJ, Song GG. Clinical findings of ankylosing spondylitis with and without human leukocyte antigen (HLA)-B27 and HLA-B51. Ann Acad Med Singap. 2019;48(10):321-329.

XXVI. Chung HY, Machado P, van der Heijde D, D'Agostino MA, Dougados M. HLA-B27 positive patients differ from HLA-B27 negative patients in clinical presentation and imaging: results from the DESIR cohort of patients with recent onset axial spondyloarthritis. Ann Rheum Dis. 2011;70(11):1930-6.

XXVII. de Winter JJ, Paramarta JE, de Jong HM, van de Sande MG, Baeten DL. Peripheral disease contributes significantly to the level of disease activity in axial spondyloarthritis. RMD Open. 2019;5(1):e000802.

XXVIII. Mease PJ, Karki C, Palmer JB, Etzel CJ, Kavanaugh A, Ritchlin CT, et al. Clinical characteristics, disease activity, and patient-reported outcomes in psoriatic arthritis patients with dactylitis or entesitis. Results from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry. Arthritis Care Res (Hoboken). 2017;69(11):1692-1699.

XXIX. Polachek A, Li S, Chandran V, Gladman DD. Clinical enthesitis in a prospective longitudinal psoriatic arthritis cohort. Incidence, prevalence, characteristics, and outcome. Arthritis Care Res (Hoboken). 2019;71(4):574.

XXX. Rezvani A, Bodur H, Ataman S, Kaya T, Buğdaycı DS, Demir SE, et al. Correlations among enthesitis, clinical, radiographic and quality of life parameters in patients with ankylosing spondylitis. Mod Rheumatol. 2014;24(4):651-6.

XXXI. Mease PJ, Liu M, Rebello S, Hua W, McLean RR, Yi E, et al. Characterization of patients with axial spondyloarthritis by enthesitis presence. Data from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry. ACR Open Rheumatol. 2020;2(7):449-456.

XXXII. Strand V, Deodhar A, Conaghan PG, et al. Assessing the humanistic and economic burden of enthesitis among patients with peripheral and axial spondyloarthritis: results from a multinational real world survey database. Arthritis Rheumatol 2019;71 Abstract 630.

XXXIII. Braun J, Khan MA, Sieper J. Enthesitis and ankylosis in spondyloarthropathy: what is the target of the immune response? Ann Rheum Dis. 2000;59(12):985-94.

XXXIV. Mease PJ, Palmer JB, Liu M, Kavanaugh A, Pandurengan R, Ritchlin CT, et al. Influence of axial involvement on cinical characteristics of psoriatic arthritis. Analysis from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry. J Rheumatol. 2018;45(10):1389-1396.

XXXV. Nadon V, Moltó A, Etcheto A, Bessette L, Michou L, D'Agostino MA, et al. Clinical peripheral enthesitis in the DESIR prospective longitudinal axial spondyloarthritis cohort. Clin Exp Rheumatol. 2019;37(4):561-565.

XXXVI. Bakirci S, Solmaz D, Stephenson W, Eder L, Roth J, Aydin SZ. Entheseal changes in response to age, body mass index, and physical activity. An ultrasound study in healthy people. J Rheumatol. 2020;47(7):968-972.

XXXVII. Eder L, Law T, Chandran V, Shanmugarajah S, Shen H, Rosen CF, et al. Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis. Arthritis Care Res (Hoboken). 2011;63(8):1091-7.

XXXVIII. Schett G, Lories RJ, D'Agostino MA, Elewaut D, Kirkham B, Soriano ER, et al. Enthesitis: from pathophysiology to treatment. Nat Rev Rheumatol. 2017;13(12):731-741.

XXXIX. Polachek A, Cook R, Chandran V, Abji F, Gladman D, Eder L. The association between HLA genetic susceptibility markers and sonographic enthesitis in psoriatic arthritis. Arthritis Rheumatol. 2019;71(4):625.

XL. Watad A, Bridgewood C, Russell T, Marzo-Ortega H, Cuthbert R, McGonagle D. The early phases of ankylosing spondylitis: emerging insights from clinical and basic science. Front Immunol. 2018;9:2668.

XLI. McGonagle DG, McInnes IB, Kirkham BW, Sherlock J, Moots R. The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies. Ann Rheum Dis. 2020;79(1):e12.

XLII. Gravallese EM, Schett G. Effects of the IL-23-IL-17 pathway on bone in spondyloarthritis. Nat Rev Rheumatol. 2018;14(11):631-640.

XLIII. Ruyssen-Witrand A, Jamard B, Cantagrel A, Nigon D, Loeuille D, Degboe Y, et al. Relationships between ultrasound enthesitis, disease activity and axial radiographic structural changes in patients with early spondyloarthritis: data from DESIR cohort. RMD Open. 2017;3(2):e000482.

XLIV. Aydin SZ, Can M, Alibaz-Oner F, Keser G, Kurum E, Inal V, et al. A relationship between spinal new bone formation in ankylosing spondylitis and the sonographically determined Achilles tendon enthesophytes. Rheumatol Int. 2016;36(3):397-404.

XLV. Polachek A, Cook R, Chandran V, Gladman DD, Eder L. The association between sonographic enthesitis and radiographic damage in psoriatic arthritis. Arthritis Res Ther. 2019;21(1):20.

XLVI. Solmaz D, Bakirci S, Jibri Z, Sampaio M, Karsh J, Aydin SZ. Psoriasis is an independent risk factor for entheseal damage in axial spondyloarthritis. Semin Arthritis Rheum. 2020;50(1):42-47.